A shadow market for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Sellers market the drug there before redirecting customers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.
Some professionals said the demand for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.
Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to fines, legal action or prison.
Service Response and Content Removal
According to TikTok, the platform has taken down violative content and banned related keywords and query recommendations. The company said it was committed to keeping the platform safe and investing in enhancing enforcement strategies.
Online Trading Activities
Investigations also found groups with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with numerous of members, populated with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at home.
After moments of joining one group, a seller posted contact information, where the majority of purchases occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about weight, health issues or past usage.
Product Information and Pricing
Inside these communities, posts display dark colored parcels with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service said it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of an online medical service linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has already seen individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company investigational substance not yet approved … may subject patients to potentially significant medical dangers”.
